Skip to main navigation Skip to search Skip to main content

4E-BP2/SH2B1/IRS2 are part of a novel feedback loop that controls β-cell mass

  • Manuel Blandino-Rosano
  • , Joshua O. Scheys
  • , Margarita Jimenez-Palomares
  • , Rebecca Barbaresso
  • , Aaron S. Bender
  • , Akiko Yanagiya
  • , Ming Liu
  • , Liangyou Rui
  • , Nahum Sonenberg
  • , Ernesto Bernal-Mizrachi

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

The mammalian target of rapamycin complex 1 (mTORC1) regulates several biological processes, although the key downstream mechanisms responsible for these effects are poorly defined. Using mice with deletion of eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2), we determine that this downstream target is a major regulator of glucose homeostasis and β-cell mass, proliferation, and survival by increasing insulin receptor substrate 2 (IRS2) levels and identify a novel feedback mechanism by which mTORC1 signaling increases IRS2 levels. In this feedback loop, we show that 4E-BP2 deletion induces translation of the adaptor protein SH2B1 and promotes the formation of a complex with IRS2 and Janus kinase 2, preventing IRS2 ubiquitination. The changes in IRS2 levels result in increases in cell cycle progression, cell survival, and β-cell mass by increasing Akt signaling and reducing p27 levels. Importantly, 4E-BP2 deletion confers resistance to cytokine treatment in vitro. Our data identify SH2B1 as a major regulator of IRS2 stability, demonstrate a novel feedback mechanism linking mTORC1 signaling with IRS2, and identify 4E-BP2 as a major regulator of proliferation and survival of β-cells.

Original languageEnglish
Pages (from-to)2235-2248
Number of pages14
JournalDiabetes
Volume65
Issue number8
DOIs
StatePublished - 1 Aug 2016

Fingerprint

Dive into the research topics of '4E-BP2/SH2B1/IRS2 are part of a novel feedback loop that controls β-cell mass'. Together they form a unique fingerprint.

Cite this